Drugs / DPV-001
last change Aug 2021 re-read 2 minutes ago

DPV-001

Vaccine

Developed for
head and neck cancer
Investigated by
Providence Health & Services

Trials 1 · a red edge is where a trial was stopped

2022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04470024 Aug 2021 → Dec 2027 expected head and neck cancer Providence Health & Services Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DPV-001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04470024
Modality Vaccine “autophagosome cancer vaccineNCT04470024